A new FDA-approved pulmonary valve should reduce the number of open-heart surgeries children with congenital heart disease require as they grow older. Emile Bacha, MD, explained the importance of this device in a new video interview. A new FDA-approved pulmonary valve should reduce the number of open-heart surgeries children with congenital heart disease require as they grow older. Emile Bacha, MD, explained the importance of this device in a new video interview. | | |
|
Certain Sapien M3 TMVR delivery systems have been linked to a risk of malfunctioning in a way that puts patients at risk. The devices included in this early alert should be returned to the manufacturer. Certain Sapien M3 TMVR delivery systems have been linked to a risk of malfunctioning in a way that puts patients at risk. The devices included in this early alert should be returned to the manufacturer. | | |
|
Cardiac surgeon compensation is up 11%, according to new survey data from MedAxiom and the American College of Cardiology. Vascular surgeons experienced an increase in pay as well, but it was much smaller. Cardiac surgeon compensation is up 11%, according to new survey data from MedAxiom and the American College of Cardiology. Vascular surgeons experienced an increase in pay as well, but it was much smaller. | | |
|
Overall, more than 950,000 clinicians submitted queries to a popular AI platform from January 2024 to June 2026. Cardiovascular care was a common topic, especially questions about specific treatments and medications. Overall, more than 950,000 clinicians submitted queries to a popular AI platform from January 2024 to June 2026. Cardiovascular care was a common topic, especially questions about specific treatments and medications. | | |
|
|
Cardiologists appear to be thriving in the face of adversity. Even as the specialty juggles an aging population, a workforce shortage and unfavorable reimbursement policies, compensation and productivity continue to climb. Cardiologists appear to be thriving in the face of adversity. Even as the specialty juggles an aging population, a workforce shortage and unfavorable reimbursement policies, compensation and productivity continue to climb. | | |
|
The first-of-its-kind platform allows operators to remove more thrombus without being concerned about blood loss. The first-of-its-kind platform allows operators to remove more thrombus without being concerned about blood loss. | | |
|
FEVAR and BEVAR transformed how complex aortic aneurysms are treated. Clinicians now have an FDA-approved bridging stent option specifically indicated for these procedures. FEVAR and BEVAR transformed how complex aortic aneurysms are treated. Clinicians now have an FDA-approved bridging stent option specifically indicated for these procedures. | | |
|
One of the world's most well-known publications just dropped a new list of 300 different inventions. Cardiologists and other cardiology professionals may recognize a few entries. One of the world's most well-known publications just dropped a new list of 300 different inventions. Cardiologists and other cardiology professionals may recognize a few entries. | | |
|
|
The new software from Chicago-based Tempus AI was designed to identify signs of moderate or severe MR. This is the company's second FDA clearance in the last two months. The new software from Chicago-based Tempus AI was designed to identify signs of moderate or severe MR. This is the company's second FDA clearance in the last two months. | | |
|
The study's authors emphasized that these data should be kept in mind when making treatment decisions for female patients with severe AS. The study's authors emphasized that these data should be kept in mind when making treatment decisions for female patients with severe AS. | | |
|
The long-term goal is to bring 24-7 cardiac care to every American, even those living in counties with no cardiologists. The long-term goal is to bring 24-7 cardiac care to every American, even those living in counties with no cardiologists. | | |
|
|
Once the deal closes, BioReference and its FDA-approved 4Kscore Test—currently owned by Opko Health—will become part of Labcorp, allowing it to expand its blood testing capabilities. Once the deal closes, BioReference and its FDA-approved 4Kscore Test—currently owned by Opko Health—will become part of Labcorp, allowing it to expand its blood testing capabilities. | | |
|
According to researchers, it is worth considering whether these findings “may precede detectable cognitive deficits” in the future. According to researchers, it is worth considering whether these findings “may precede detectable cognitive deficits” in the future. | | |
|
